Best-Available Therapy(BAT) Regimen Clinical Trials

1 actively recruiting trial

Also known as: FLAG/CLAG/MAE/DCAG/HAA/HAD Regimen

Pipeline

Phase 2: 1

Top Sponsors

Chinese PLA General Hospital1

Indications

Relapsed/Refractory Acute Myeloid Leukemia1
Cancer1

Other1 trial

Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.